Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 25, Number 3—March 2019
Research Letter

Mycobacterium chimaera Pulmonary Disease in Cystic Fibrosis Patients, France, 2010–2017

Romaric LarcherComments to Author , Manon Lounnas, Yann Dumont, Anne-Laure Michon, Lucas Bonzon, Raphael Chiron, Christian Carriere, Kada Klouche, and Sylvain Godreuil
Author affiliations: University of Montpellier, Montpellier, France (R. Larcher, M. Lounnas, C. Carriere, K. Klouche, S. Godreuil); Montpellier University Hospital, Montpellier (R. Larcher, Y. Dumont, A.-L. Michon, L. Bonzon, R. Chiron, C. Carriere, K. Klouche, S. Godreuil)

Main Article

Figure

Evolution of lung function for 4 cystic fibrosis patients with Mycobacterium chimaera pulmonary disease, France, 2010–2017. A) Case-patient 1, B) case-patient 2, C) Case-patient 3, D) Case-patient 4. Case-patients 1 and 3 were given specific treatment for M. chimaera disease for 3 months; case-patient 2 was not given specific treatment; case-patient 4 was given only partial treatment. FEV1, forced expiratory volume in 1 s; FVC, forced vital capacity.

Figure. Evolution of lung function for 4 cystic fibrosis patients with Mycobacterium chimaera pulmonary disease, France, 2010–2017. A) Case-patient 1, B) case-patient 2, C) case-patient 3, D) case-patient 4. Case-patients 1 and 3 were given specific treatment for M. chimaera disease for 3 months; case-patient 2 was not given specific treatment; case-patient 4 was given only partial treatment. FEV1, forced expiratory volume in 1 s; FVC, forced vital capacity.

Main Article

Page created: February 19, 2019
Page updated: February 19, 2019
Page reviewed: February 19, 2019
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external